Small Caps Squeeze 🚀 Biotech Breakout & Tesla’s Robotaxi Run
Jordan, Shay Boloor, and Michael Nauss, CMT dig into the week’s wild action: why small caps keep ripping despite record short interest, the CRISPR/biotech re-rating (and what just lit a fire under $NTLA), and how Tesla’s pivot to physical AI (robotaxi + Optimus + megapacks) could reset the narrative. We also hit stage-two AI winners (apps > infra), the “big base → high in space” playbook, 2026 cycle risks, and whether $OPEN’s story is more than a squeeze.
Chapters
00:00 Intro & week recap (volatility, FOMC “nothing burger”)
01:10 Seasonality when above the 200-DMA; small caps at ATH with shorts piled on
02:24 What derails the uptrend? If anything, it’s geopolitical
05:00 Biotech rotation: CRISPR names ($CRSP $NTLA $BEAM $PRME) and M&A tailwinds
06:07 XBI anchored-VWAP breakout logic; winners vs junk in biotech
08:38 Why $NTLA’s phase 3 enrollment milestone mattered
11:41 AI stage two: from chips to software moats; who benefits
15:13 Valuations vs growth: $GOOGL, hyperscalers, and AI margin levers
17:02 Neo-clouds & power plays; Microsoft stamp-of-approval chatter
19:29 The “big base” strategy: $INTC, $BIDU, $ROKU, $PTON (and what not to chase)
21:45 $CVNA puzzle; when to just pass
22:35 $TTD patience vs proof
24:08 Nuclear momentum: $OKLO and the SMR trade (know your risk)
25:08 Macro cycle chat: why many have 2026 circled
29:18 How to invest through sideways markets (and keep boredom from killing you)
30:02 Index path vs micro bubbles; where pullbacks likely hit hardest
31:31 Palantir debate: growth re-accel, margins, and what the valuation implies ($PLTR)
42:49 Tesla deep-dive: robotaxi/Optimus, data + HW integration, grid monetization ($TSLA)
47:25 What would make Shay add more $TSLA; city-by-city rollout realities
50:04 Multiple super-cycles at once: AI, space, quantum, electrification
50:41 Meme & squeeze corner: $OPEN setup and pair-trade dynamics
56:12 The power of a “retail whisperer” and why storytelling matters
1:01:20 Raises/dilution in a forgiving tape; who should tap markets now
1:01:32 Redwire cautionary tale; why management quality is everything
1:02:57 Wrap & weekend send-off
Tickers Mentioned (not advice):
$IWM $IWC $XBI $CRSP $NTLA $BEAM $PRME $PLTR $NET $SNOW $MDB $ZS $GOOGL $MSFT $AMZN $OKLO $IONQ $INTC $BIDU $ROKU $PTON $CVNA $TTD $OPEN $QUBT $RDW
Key Takeaways:
* Shorts are maxed in small caps; dips likely get bought until a real blow-up forces covers.
* Biotech/CRISPR is re-rating on data + M&A optionality; expect dispersion—know your science.
* AI “stage two” = software moats and distribution, not just GPUs.
* Tesla is increasingly a physical AI story (robotaxi + humanoids + energy), not “just cars.”
* 2026 is a risk window; plan for chop even if the secular uptrend stays intact.
If you learned something, smash 👍, subscribe, and catch us live next week. Trade safe!
